ST人福 (600079)
Humanwell Healthcare (Group) Co., Ltd.
K-Line Chart
No K-line data available
Company NameHumanwell Healthcare Group Co., Ltd.
Listing Date1997-06-06
Issue Price5.22RMB
Registered Capital163222.596510k RMB
Legal RepresentativeHansheng Zhou
Registered AddressNo. 666 Gaoxin Avenue, East Lake High-Tech Development Zone, Wuhan, Hubei Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, sales, and technical services of pharmaceuticals, medical devices, reproductive health products and related technologies; real estate development and sales.
Company ProfileHumanwell Healthcare Group Co., Ltd. was founded in 1993 and listed on the Shanghai Stock Exchange in 1997 (Stock Code: 600079.SH). It is the first listed private high-tech enterprise in Hubei Province and the first listed company in Wuhan East Lake High-Tech Development Zone. After more than 20 years of development, it has become a leading pharmaceutical industrial enterprise in Hubei Province, one of China's Top 100 Pharmaceutical Industrial Enterprises, one of China's Top 500 Private Enterprises, and a National Science and Technology Innovation Demonstration Enterprise.
Stock Details
1. Key Indicators
- Total Shares(W): 163222.60
- Circulating A-Shares(W): 154317.88
- Earnings Per Share(RMB): 1.0300
- Net Assets Per Share(RMB): 11.5877
- Operating Revenue(W RMB): 1788335.25
- Total Profit(W RMB): 263166.06
- **Net Profit Attributable to Parent(W RMB) **: 168857.65
- Net Profit Growth Rate(%): 6.22
- Weighted Return on Equity(%): 9.2000
- Operating Cash Flow Per Share(RMB): 1.0100
- Undistributed Profit Per Share(RMB): 6.5889
- Capital Reserve Per Share(RMB): 3.4830
2. Main Business
The main business covers:
- Production, research and development, and sales of pharmaceutical industry products
3. Company Basic Information
- Company Name: Humanwell Healthcare Group Co., Ltd.
- Listing Date: 1997-06-06
- Industry: Pharmaceutical Manufacturing
- Address: No. 666 Gaoxin Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province
- Website: https://www.humanwell.com.cn
- Company Profile: The company was jointly established in March 1993 by three companies including China Humanwell New Technology Development Center. It started with 30.30 million sponsor shares converted from cash and other assets, and raised 1.20 million corporate shares and 6.00 million employee shares. After the issuance on May 22, 1997, the total share capital at the time of listing reached 57.50 million shares. The employee shares became tradable on the Shanghai Stock Exchange three years after the 20.00 million public shares started trading on June 6, 1997.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | COFCO Trust Co., Ltd. - COFCO Trust - Chunni No. 1 Bankruptcy Restructuring Service Trust | Asset Management Plan | 19090.03 | 12.37 |
| 2 | China Merchants Biotech Investment Development (Wuhan) Partnership (Limited Partnership) | General Legal Person | 9793.36 | 6.35 |
| 3 | China Merchants Life Science and Technology (Wuhan) Co., Ltd. | General Legal Person | 7332.95 | 4.75 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 4218.32 | 2.73 |
| 5 | Wuhu Xinfu Equity Investment Partnership (Limited Partnership) | General Legal Person | 2828.24 | 1.83 |
| 6 | Wuhan High-tech State-owned Holding Group Co., Ltd. | General Legal Person | 2618.72 | 1.70 |
| 7 | Penghua Jiangxin Jingxuan Mixed Securities Investment Fund Class A | Fund | 2347.22 | 1.52 |
| 8 | Ping An Anying Stock-type Pension Product - Bank of China Limited | General Legal Person | 1741.88 | 1.13 |
| 9 | Harvest Emerging Industries Stock Securities Investment Fund | Fund | 1311.27 | 0.85 |
| 10 | Harvest Core Growth Mixed Securities Investment Fund Class A | Fund | 1074.84 | 0.70 |
5. Concept Sectors
- Biological Vaccine
- Private Hospital
- Vitamin
- Artificial Intelligence
- Generic Drug
- Hepatitis Concept
- Innovative Drug
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information